Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates

RTTNews | 1121 dias atrás
Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates

(RTTNews) - While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2022. The company also issued outlook for the third quarter.

For fiscal 2022, the company continues to project adjusted earnings in a range of $3.21 to $3.29 per share on revenues between $1.557 billion and $1.575 billion, with organic revenue growth of 4.0 to 5.2 percent, based on better than expected first half performance.

Previously, the company expected adjusted earnings in a range of $3.27 to $3.35 per share on revenues between $1.58 billion and $1.60 billion, with organic revenue growth of 3.8 to 5.2 percent.

On average, 11 analysts polled by Thomson Reuters expect the company to report earnings of $3.31 per share on revenues of $1.59 billion for the year. Analysts' estimates typically exclude special items.

For the third quarter, the company expects adjusted earnings in a range of $0.78 to $0.82 per share on revenues between $383 million and $391 million, with organic revenue growth of 2.6 to 4.8 percent.

The Street is looking for earnings of $0.84 per share on revenues of $398.66 million for the quarter.

For the second quarter, the Company reported net income of $44.79 million or $0.54 per share, up from $35.07 million or $0.41 per share in the prior-year quarter. Excluding items, adjusted earnings for the quarter was $0.82 per share, compared to $0.79 per share in the year-ago quarter.

Total revenues for the quarter increased 2.0 percent to $397.82 million from $389.99 million in the same quarter last year. Organic revenue grew 4.8 percent.

Analysts expected the company to report earnings of $0.80 per share on revenues of $395.27 million for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Etiquetas: IART
read more
Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Medical technology firm Integra LifeSciences Holdings Corp. (IART) announced Wednesday that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company, for $275 million in cash at closing. This is subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
RTTNews | 617 dias atrás
Swiss Market Ends Weak

Swiss Market Ends Weak

The Switzerland market ended modestly lower on Thursday after languishing in negative territory right through the day's trading session, as the mood remained cautious with investors looking ahead to speeches from central bank chiefs at Federal Reserve's Jackson Hole Symposium.
RTTNews | 7 h 27 min atrás
European Stocks Close On Mixed Note Again

European Stocks Close On Mixed Note Again

European stocks turned in another mixed performance as investors stayed a bit cautious on Thursday, looking ahead to Federal Reserve's symposium at Jackson Hole, Wyoming, and largely shrugging off trade concerns. Investors also digested the latest batch of regional economic data, including flash estimates of manufacturing and services sector activity in the major economies.
RTTNews | 7 h 43 min atrás
Eurozone Consumer Confidence Weakens More Than Expected In August

Eurozone Consumer Confidence Weakens More Than Expected In August

Euro area consumer sentiment deteriorated more than expected in August to a four-month low, after a strong improvement in the previous month, preliminary results of the monthly survey by the European Commission revealed on Thursday.
RTTNews | 8 h 32 min atrás
U.S. Leading Economic Index Edges Down In Line With Estimates In July

U.S. Leading Economic Index Edges Down In Line With Estimates In July

A reading on leading U.S. economic indicators edged slightly lower in the month of July, according to a report released by the Conference Board on Thursday. The Conference Board said leading economic index slipped by 0.1 percent in July after falling by 0.3 percent in June. The modest decrease matched economist estimates.
RTTNews | 10 h 26 min atrás
U.S. Existing Home Sales Unexpectedly Rebound In July

U.S. Existing Home Sales Unexpectedly Rebound In July

The National Association of Realtors released a report on Thursday showing an unexpected rebound by existing home sales in the U.S. in the month of July. The report said existing home sales jumped by 2.0 percent to an annual rate of 4.01 million in July after tumbling by 2.7 percent to an annual rate of 3.93 million in June.
RTTNews | 10 h 37 min atrás